296 related articles for article (PubMed ID: 16765439)
1. T-type calcium channels and tumor proliferation.
Panner A; Wurster RD
Cell Calcium; 2006 Aug; 40(2):253-9. PubMed ID: 16765439
[TBL] [Abstract][Full Text] [Related]
2. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
[TBL] [Abstract][Full Text] [Related]
3. T-type CaV3.3 calcium channels produce spontaneous low-threshold action potentials and intracellular calcium oscillations.
Chevalier M; Lory P; Mironneau C; Macrez N; Quignard JF
Eur J Neurosci; 2006 May; 23(9):2321-9. PubMed ID: 16706840
[TBL] [Abstract][Full Text] [Related]
4. A role for voltage gated T-type calcium channels in mediating "capacitative" calcium entry?
Gackière F; Bidaux G; Lory P; Prevarskaya N; Mariot P
Cell Calcium; 2006 Apr; 39(4):357-66. PubMed ID: 16442617
[TBL] [Abstract][Full Text] [Related]
5. T-type Ca2+ channels in vascular smooth muscle: multiple functions.
Cribbs LL
Cell Calcium; 2006 Aug; 40(2):221-30. PubMed ID: 16797699
[TBL] [Abstract][Full Text] [Related]
6. T-type voltage-activated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF-7 human breast cancer cells.
Ohkubo T; Yamazaki J
Int J Oncol; 2012 Jul; 41(1):267-75. PubMed ID: 22469755
[TBL] [Abstract][Full Text] [Related]
7. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.
Horiba M; Muto T; Ueda N; Opthof T; Miwa K; Hojo M; Lee JK; Kamiya K; Kodama I; Yasui K
Life Sci; 2008 Mar; 82(11-12):554-60. PubMed ID: 18275974
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular T-type calcium channels: physiological and pharmacological significance.
Triggle DJ
J Hypertens Suppl; 1997 Dec; 15(5):S9-15. PubMed ID: 9481611
[TBL] [Abstract][Full Text] [Related]
9. Low-voltage-activated (T-type) calcium channels control proliferation of human pulmonary artery myocytes.
Rodman DM; Reese K; Harral J; Fouty B; Wu S; West J; Hoedt-Miller M; Tada Y; Li KX; Cool C; Fagan K; Cribbs L
Circ Res; 2005 Apr; 96(8):864-72. PubMed ID: 15774856
[TBL] [Abstract][Full Text] [Related]
10. T-type Ca2+ channel blockers suppress the growth of human cancer cells.
Heo JH; Seo HN; Choe YJ; Kim S; Oh CR; Kim YD; Rhim H; Choo DJ; Kim J; Lee JY
Bioorg Med Chem Lett; 2008 Jul; 18(14):3899-901. PubMed ID: 18585035
[TBL] [Abstract][Full Text] [Related]
11. The role of voltage gated T-type Ca2+ channel isoforms in mediating "capacitative" Ca2+ entry in cancer cells.
Gray LS; Perez-Reyes E; Gomora JC; Haverstick DM; Shattock M; McLatchie L; Harper J; Brooks G; Heady T; Macdonald TL
Cell Calcium; 2004 Dec; 36(6):489-97. PubMed ID: 15488598
[TBL] [Abstract][Full Text] [Related]
12. Role of voltage-gated calcium channels in potassium-stimulated aldosterone secretion from rat adrenal zona glomerulosa cells.
Uebele VN; Nuss CE; Renger JJ; Connolly TM
J Steroid Biochem Mol Biol; 2004 Oct; 92(3):209-18. PubMed ID: 15555914
[TBL] [Abstract][Full Text] [Related]
13. Voltage-gated K+ channels are associated with cell proliferation and cell cycle of ovarian cancer cell.
Zhanping W; Xiaoyu P; Na C; Shenglan W; Bo W
Gynecol Oncol; 2007 Feb; 104(2):455-60. PubMed ID: 17014896
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and SAR studies of a novel series of T-type calcium channel blockers.
Park SJ; Park SJ; Lee MJ; Rhim H; Kim Y; Lee JH; Chung BY; Lee JY
Bioorg Med Chem; 2006 May; 14(10):3502-11. PubMed ID: 16434203
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibition of human cancer cells in vitro by T-type calcium channel blockers.
Lee JY; Park SJ; Park SJ; Lee MJ; Rhim H; Seo SH; Kim KS
Bioorg Med Chem Lett; 2006 Oct; 16(19):5014-7. PubMed ID: 16876410
[TBL] [Abstract][Full Text] [Related]
16. Ca2+ channel subtypes and pharmacology in the kidney.
Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
[TBL] [Abstract][Full Text] [Related]
17. 3,4-Dihydroquinazoline derivatives as novel selective T-type Ca2+ channel blockers.
Lee YS; Lee BH; Park SJ; Kang SB; Rhim H; Park JY; Lee JH; Jeong SW; Lee JY
Bioorg Med Chem Lett; 2004 Jul; 14(13):3379-84. PubMed ID: 15177437
[TBL] [Abstract][Full Text] [Related]
18. Acidic extracellular pH increases calcium influx-triggered phospholipase D activity along with acidic sphingomyelinase activation to induce matrix metalloproteinase-9 expression in mouse metastatic melanoma.
Kato Y; Ozawa S; Tsukuda M; Kubota E; Miyazaki K; St-Pierre Y; Hata R
FEBS J; 2007 Jun; 274(12):3171-83. PubMed ID: 17540003
[TBL] [Abstract][Full Text] [Related]
19. The pharmacology and regulation of T type calcium channels: new opportunities for unique therapeutics for cancer.
Gray LS; Macdonald TL
Cell Calcium; 2006 Aug; 40(2):115-20. PubMed ID: 16806465
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive effects of the putative T-type calcium channel antagonist mibefradil are mediated by the L-type calcium channel Cav1.2.
Moosmang S; Haider N; Brüderl B; Welling A; Hofmann F
Circ Res; 2006 Jan; 98(1):105-10. PubMed ID: 16306443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
